TheraME! AG

Personalized cancer therapy

TheraMe! AG, a spin-off from EPFL, is a MedTech startup based in Lausanne that provides personalized cancer therapy recommendation before treatment starts. We employ proprietary microfluidic technologies to test the efficacy of cancer drugs on freshly isolated patients' tumor cells to determine the best therapy for each patient.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No milestones

No Jobs

No videos and documents

EPFL Spin-Off

Website

TheraME! AG

Personalized cancer therapy

Headquarter:
Ecublens

Foundation Date:
January 2023

Technology:

  • Biotech